Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Oligodendroglioma × BID protein, human × Clear all

Sponsor

Conditions

Neoplasms 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Urinary Bladder Neoplasms 1 Solid Tumor 1 Ovarian Neoplasms 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 NSCLC 1 Myeloproliferative Disorders 1 Lymphoma, T-Cell, Cutaneous 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid 1 Leukemia 1 Hematologic Diseases 1 Head and Neck Neoplasms 1 Glioblastoma 1 Bone Marrow Diseases 1 Advanced Solid Tumor 1 Adenocarcinoma of Lung 1

Interventions

Temozolomide 14 Bevacizumab 11 Erlotinib Hydrochloride 5 Radiotherapy 4 Carboplatin 4 Irinotecan 3 Immunoglobulin G 3 Disulfides 3 poly ICLC 2 palbociclib 2 etoposide phosphate 2 Vincristine 2 Sunitinib 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 Dasatinib 2 veliparib 1 varlilumab 1 vandetanib 1 trebananib 1 trametinib 1 terameprocol 1 temsirolimus 1 tandutinib 1 selinexor 1 romidepsin 1 picropodophyllin 1 pemigatinib 1 niraparib 1 nintedanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡